The life and times of Richard L. Rauck (1956–2025)
-
By
-
James C. Eisenach
-
May 8, 2026
-
0 min
Clinical Report: A Tribute to Richard L. Rauck (1956–2025): His Impact on Pain Medicine
Overview
Richard L. Rauck significantly advanced pain medicine through his clinical practice, research, and education. His contributions to interventional pain management and the establishment of pain clinics have left a lasting legacy in the field.
Background
The evolution of pain medicine has been marked by increased awareness and the development of advanced treatment modalities. Richard Rauck played a pivotal role during a transformative period, advocating for patient-centered care and ethical practices in pain management. His work not only influenced clinical practices but also shaped the training of future pain specialists.
Data Highlights
No numerical data or trial data available in the article.
Key Findings
- Rauck was instrumental in the establishment of pain clinics during the rapid expansion of pain medicine from the mid-1980s to mid-2000s.
- He emphasized the importance of patient care and education in the use of invasive procedures and pharmacotherapy.
- Rauck directed a Phase III study leading to FDA authorization of epidural clonidine for refractory cancer pain.
- He was a prolific researcher with over 200 published works, contributing significantly to the understanding of spinal drug treatments.
- Rauck founded the Carolinas Pain Institute, continuing his commitment to education and research in a private practice setting.
Clinical Implications
Clinicians should recognize the importance of patient-centered approaches in pain management, as exemplified by Rauck's career. Ongoing education and ethical considerations in the use of interventional techniques are essential for advancing the field of pain medicine.
Conclusion
Richard Rauck's legacy in pain medicine is characterized by his dedication to patient care, education, and ethical practice. His contributions will continue to influence the field for years to come.
Related Resources & Content
- Richard Pazdur, MD, Honored With 2025 AACR Enduring Impact Award for Transformative Service to Cancer Science and Medicine
- Richard Pazdur, MD, Receives AACR Public Service Award
- Expert Point of View: Brian D. Kavanagh, MD, MPH, FASTRO, and Zain A. Husain, MD
- Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain
- Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover
- The ASCO Post — Peter Jacobs, MD, Storied South African Hematology Pioneer, Dies
- The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain - PubMed
- Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover - PubMed
- Health Technology Clinical Committee Final Findings and Decision SCS
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.